Expect a response soon from one of our experts.
Discover JAX's Oncology models and efficacy studies. Evaluate your CAR or Antibody based therapeutics using JAX's cutting-edge immune-humanized mice featuring characterized PDX tumors.
Read MoreAnalyze the human immune and tumor environment to assess the efficacy of your therapeutic through a safety or pharmacokinetic in vivo study using a mouse model with a humanized immune system.
Read MoreAssess therapeutic antibodies and compounds, which include preclinical studies on GvHD using immune humanized mouse models incorporating CD34+ and PBMC donors.
Read MoreStay informed about our events, blogs and videos, and cutting-edge research platforms.
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.